Patents by Inventor Zhengbang CHEN

Zhengbang CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Silicon-containing compound for resistance to hepatitis C virus infection
    Patent number: 10766912
    Abstract: The present invention provides a silicon-containing compound for resistance to hepatitis c virus infection, and in particular provides a compound represented by formula I, or a pharmaceutically acceptable salt, or a tautomer, or a stereoisomer, or a deuterated compound thereof and mixture among them, a preparation process therefor, and a pharmaceutical composition comprising the same. The present application also provides a use of the compound, or a pharmaceutically acceptable salt, or a tautomer, or a stereoisomer, or a deuterated compound thereof and mixture among them, and a pharmaceutical composition comprising the same in treatment of hepatitis c virus infection.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: September 8, 2020
    Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Inventors: Yinsheng Zhang, Baomin Liu, Yu Huang, Zhengbang Chen, Kuo Gai, Xushi Liu, Xiaojin Wang, Hongjiang Xu
  • SILICON-CONTAINING COMPOUND FOR RESISTANCE TO HEPATITIS C VIRUS INFECTION
    Publication number: 20200017532
    Abstract: The present invention provides a silicon-containing compound for resistance to hepatitis c virus infection, and in particular provides a compound represented by formula I, or a pharmaceutically acceptable salt, or a tautomer, or a stereoisomer, or a deuterated compound thereof and mixture among them, a preparation process therefor, and a pharmaceutical composition comprising the same. The present application also provides a use of the compound, or a pharmaceutically acceptable salt, or a tautomer, or a stereoisomer, or a deuterated compound thereof and mixture among them, and a pharmaceutical composition comprising the same in treatment of hepatitis c virus infection.
    Type: Application
    Filed: March 22, 2018
    Publication date: January 16, 2020
    Inventors: Yinsheng ZHANG, Baomin LIU, Yu HUANG, Zhengbang CHEN, Kuo GAI, Xushi LIU, Xiaojin WANG, Hongjiang XU